2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference91 articles.
1. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study;Frost;Arch Intern Med,2004
2. Increased risk of venous thromboembolism among patients with hyperthyroidism: a systematic review and meta-analysis of cohort studies;Srisawat;Eur J Intern Med,2019
3. Incidence and mortality of myocardial infarction and stroke in patients with hyperthyroidism: A Nationwide Cohort Study in Korea;Kim;Thyroid,2020
4. Antipsychotics in hyperthyroid-related psychosis: case report and systematic review;Golub;Neuro Endocrinol Lett,2018
5. Thyrotoxic periodic paralysis and complicated thyrotoxicosis, two presentations of hyperthyroidism with notable differences in their clinical manifestations: an experience from a Tertiary Care Hospital in the United States;Rivas;Endocr Pract,2020
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease;Eye and Vision;2024-09-06
2. Identification and functionalization of thyrotropin receptor antibodies with different antigenic epitopes;American Journal of Physiology-Endocrinology and Metabolism;2024-09-01
3. Petal-shaped corneal pattern in a patient with posterior amorphous corneal dystrophy;American Journal of Ophthalmology Case Reports;2024-09
4. The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta‐analysis of randomised controlled trials;Clinical Endocrinology;2024-08-13
5. Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system;Frontiers in Pharmacology;2024-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3